RT Conference Proceedings
T1 Nivolumab and ipilimumab (N plus I) is active in patients (pts) with metastatic uveal melanoma (mUM) with extra-hepatic only involvement: Pooled analysis from 2 phase II trials
A1 Piulats Rodriguez, J. M.
A1 Patel, S.
A1 Espinosa, E.
A1 Pelster, M. S.
A1 de la Cruz Merino, L.
A1 Khoja, L. T.
A1 Joshua, A. M.
A1 Tebe, C.
A1 Berrocal, A.
PB Elsevier
SN 0923-7534
YR 2020
FD 2020-09-01
LK https://hdl.handle.net/10668/27551
UL https://hdl.handle.net/10668/27551
LA en
DS RISalud
RD Apr 19, 2025